Difficulties with communication and social interaction are common issues for those with autism spectrum disorder (ASD). In the IRIS research study - we are looking to find out whether an investigational drug might improve the symptoms of ASD that often make social interaction challenging. The IRIS study will compare an investigational medication to placebo to determine how it might affect communication, behavior, and other symptoms in people ages 12-45 with ASD. The study will last about 26 weeks and will require 10 study visits to the University of South Florida, Department of Psychiatry and Behavioral Neurosciences.
Criteria:Be 12-45 years of age
Have a diagnosis of autism spectrum disorder (ASD)
Have a relative, housemate, friend, or other study partner to assist during the study and attend clinic visits
Additional eligibility criteria applies